Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (116)
2025 (1325)
2024 (1331)
2023 (1277)
2022 (1392)
2021 (1425)
2020 (1224)
2019 (1083)
2018 (1143)
2017 (1036)
2016 (936)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (14812)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Genome Med
JSON
ISSN
1756-994X
ISSN-L
1756-994X
IUID
8739bb081ff443258539f5d55ffbe740
Modified
2020-11-27T13:12:56.945Z
Created
2018-12-05T09:43:15.096Z
Year 2025
PubMed
DOI
Crossref
varCADD: large sets of standing genetic variation enable genome-wide pathogenicity prediction.
Nazaretyan L
,
Rentzsch P
,
Kircher M
Genome Med
17
(1) 84 [2025-08-04; online 2025-08-04]
PubMed
DOI
Crossref
The dynamics of the gut microbiota in prediabetes during a four-year follow-up among European patients-an IMI-DIRECT prospective study.
Lyu L, Fan Y, Vogt JK, ..., Pearson E, Pedersen O
Genome Med
17
(1) 78 [2025-07-15; online 2025-07-15]
PubMed
DOI
Crossref
Longitudinal analysis of genetic and environmental interplay in human metabolic profiles and the implication for metabolic health.
Wang J, Zenere A, Wang X, ..., Uhlén M, Zhong W
Genome Med
17
(1) 68 [2025-06-17; online 2025-06-17]
DDLS Fellow
Fredrik Edfors
Year 2023
PubMed
DOI
Crossref
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D, Talouarn E, Marchal A, ..., Abel L,
Cobat A
Genome Med
15
(1) 22 [2023-04-05; online 2023-04-05]
Year 2022
PubMed
DOI
Crossref
Loss of Y in leukocytes as a risk factor for critical COVID-19 in men.
Bruhn-Olszewska B
,
Davies H
,
Sarkisyan D
, ...,
Frithiof R
,
Dumanski JP
Genome Med
14
(1) 139 [2022-12-14; online 2022-12-14]
PubMed
DOI
Crossref
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.
Berrino E, Annaratone L, Bellomo SE, ..., Sapino A,
Marchiò C
Genome Med
14
(1) 98 [2022-08-29; online 2022-08-29]
Year 2021
PubMed
DOI
Crossref
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.
Stranneheim H, Lagerstedt-Robinson K, Magnusson M, ..., Lindstrand A,
Wedell A
Genome Med
13
(1) 40 [2021-03-17; online 2021-03-17]
Year 2020
PubMed
DOI
Crossref
Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study.
Gudmundsdottir V, Pedersen HK, Mazzoni G, ..., Pedersen O,
Brunak S
Genome Med
12
(1) 109 [2020-12-01; online 2020-12-01]
PubMed
DOI
Crossref
Whole-genome sequence association analysis of blood proteins in a longitudinal wellness cohort.
Zhong W, Gummesson A, Tebani A, ..., Fagerberg L,
Uhlén M
Genome Med
12
(1) 53 [2020-06-23; online 2020-06-23]
DDLS Fellow
Fredrik Edfors
PubMed
DOI
Crossref
Epigenome-wide meta-analysis of blood DNA methylation in newborns and children identifies numerous loci related to gestational age.
Merid SK, Novoloaca A, Sharp GC, ..., London SJ,
Melén E
Genome Med
12
(1) 25 [2020-03-02; online 2020-03-02]
PubMed
DOI
Crossref
Towards a European health research and innovation cloud (HRIC).
Aarestrup FM, Albeyatti A, Armitage WJ, ..., Van den Bulcke M, Van Oyen H
Genome Med
12
(1) 18 [2020-02-19; online 2020-02-19]
Year 2019
PubMed
DOI
Crossref
From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
Lindstrand A
, Eisfeldt J, Pettersson M, ..., Lundin J, Nilsson D
Genome Med
11
(1) 68 [2019-11-07; online 2019-11-07]
PubMed
DOI
Crossref
A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases.
Gawel DR, Serra-Musach J, Lilja S, ..., Gustafsson M,
Benson M
Genome Med
11
(1) 47 [2019-07-30; online 2019-07-30]
Antonio Lentini
DDLS Fellow
Year 2018
PubMed
DOI
Crossref
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Mayrhofer M, De Laere B, Whitington T, ..., Grönberg H, Lindberg J
Genome Med
10
(1) 85 [2018-11-21; online 2018-11-21]
PubMed
DOI
Crossref
Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.
Kundu S, Ali MA, Handin N, ..., Hellström M, Sjöblom T
Genome Med
10
(1) 2 [2018-01-04; online 2018-01-04]
Year 2017
PubMed
DOI
Crossref
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans.
Gottlieb A
, Daneshjou R, DeGorter M, ..., Montgomery SB, Altman RB
Genome Med
9
(1) 98 [2017-11-24; online 2017-11-24]
PubMed
DOI
Crossref
Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes.
Väremo L, Henriksen TI, Scheele C, ..., Pedersen BK,
Nielsen J
Genome Med
9
(1) 47 [2017-05-25; online 2017-05-25]
Year 2014
PubMed
DOI
Crossref
Fourth-generation sequencing in the cell and the clinic.
Mignardi M, Nilsson M
Genome Med
6
(4) 31 [2014-04-28; online 2014-04-28]
Year 2012
PubMed
DOI
Crossref
Comprehensive analysis of the genome transcriptome and proteome landscapes of three tumor cell lines.
Akan P, Alexeyenko A, Costea PI, ..., Uhlén M, Lundeberg J
Genome Med
4
(11) 86 [2012-11-18; online 2012-11-18]
SciLifeLab Data Centre
Publications
9.5.2